Siddhartha Saha1, Mandeep Chadha2, Abdullah Al Mamun3, Mahmudur Rahman4, Katharine Sturm-Ramirez3, Malinee Chittaganpitch5, Sirima Pattamadilok5, Sonja J Olsen6, Ondri Dwi Sampurno7, Vivi Setiawaty7, Krisna Nur Andriana Pangesti7, Gina Samaan8, Sibounhom Archkhawongs9, Phengta Vongphrachanh9, Darouny Phonekeo9, Andrew Corwin10, Sok Touch11, Philippe Buchy12, Nora Chea13, Paul Kitsutani14, Le Quynh Mai15, Vu Dinh Thiem15, Raymond Lin16, Constance Low16, Chong Chee Kheong17, Norizah Ismail18, Mohd Apandi Yusof19, Amado Tandoc20, Vito Roque21, Akhilesh Mishra2, Ann C Moen22, Marc-Alain Widdowson22, Jeffrey Partridge23, Renu B Lal3. 1. Center for Disease Control and Prevention, Influenza Programme, c/o US Embassy, Shanti Path, Chanakyapuri, New Delhi, India . 2. National Institute of Virology, Pune, India . 3. International Centre for Diarrhoeal Disease Research Bangladesh, Dhaka, Bangladesh . 4. Institute of Epidemiology, Disease Control and Research, Dhaka, Bangladesh . 5. National Institute of Health, Ministry of Public Health, Nonthaburi, Thailand . 6. Center for Disease Control and Prevention, Influenza Programme, Nonthaburi, Thailand . 7. Ministry of Health, Jakarta, Indonesia . 8. Center for Disease Control and Prevention, Jakarta, Indonesia . 9. Ministry of Health, Vientiane, Lao People's Democratic Republic. 10. Center for Disease Control and Prevention, Influenza Programme, Vientiane, Lao People's Democratic Republic. 11. Ministry of Health, Phnom Penh, Cambodia . 12. Pasteur Institute, Phnom Penh, Cambodia . 13. World Health Organization, Phnom Penh, Cambodia . 14. Center for Disease Control and Prevention, Influenza Programme, Phnom Penh, Cambodia . 15. National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam . 16. Ministry of Health, Singapore . 17. Ministry of Health, Kuala Lumpur, Malaysia . 18. National Public Health Laboratory, Kuala Lumpur, Malaysia . 19. Institute of Medical Research, Kuala Lumpur, Malaysia . 20. Research Institute for Tropical Medicine, Alabang, Philippines . 21. Department of Health, Manila, Philippines . 22. Centers for Disease Control and Prevention, Atlanta, United States of America . 23. Center for Disease Control and Prevention, Influenza Programme, Hanoi, Viet Nam .
Abstract
OBJECTIVE: To characterize influenza seasonality and identify the best time of the year for vaccination against influenza in tropical and subtropical countries of southern and south-eastern Asia that lie north of the equator. METHODS: Weekly influenza surveillance data for 2006 to 2011 were obtained from Bangladesh, Cambodia, India, Indonesia, the Lao People's Democratic Republic, Malaysia, the Philippines, Singapore, Thailand and Viet Nam. Weekly rates of influenza activity were based on the percentage of all nasopharyngeal samples collected during the year that tested positive for influenza virus or viral nucleic acid on any given week. Monthly positivity rates were then calculated to define annual peaks of influenza activity in each country and across countries. FINDINGS: Influenza activity peaked between June/July and October in seven countries, three of which showed a second peak in December to February. Countries closer to the equator had year-round circulation without discrete peaks. Viral types and subtypes varied from year to year but not across countries in a given year. The cumulative proportion of specimens that tested positive from June to November was > 60% in Bangladesh, Cambodia, India, the Lao People's Democratic Republic, the Philippines, Thailand and Viet Nam. Thus, these tropical and subtropical countries exhibited earlier influenza activity peaks than temperate climate countries north of the equator. CONCLUSION: Most southern and south-eastern Asian countries lying north of the equator should consider vaccinating against influenza from April to June; countries near the equator without a distinct peak in influenza activity can base vaccination timing on local factors.
OBJECTIVE: To characterize influenza seasonality and identify the best time of the year for vaccination against influenza in tropical and subtropical countries of southern and south-eastern Asia that lie north of the equator. METHODS: Weekly influenza surveillance data for 2006 to 2011 were obtained from Bangladesh, Cambodia, India, Indonesia, the Lao People's Democratic Republic, Malaysia, the Philippines, Singapore, Thailand and Viet Nam. Weekly rates of influenza activity were based on the percentage of all nasopharyngeal samples collected during the year that tested positive for influenza virus or viral nucleic acid on any given week. Monthly positivity rates were then calculated to define annual peaks of influenza activity in each country and across countries. FINDINGS: Influenza activity peaked between June/July and October in seven countries, three of which showed a second peak in December to February. Countries closer to the equator had year-round circulation without discrete peaks. Viral types and subtypes varied from year to year but not across countries in a given year. The cumulative proportion of specimens that tested positive from June to November was > 60% in Bangladesh, Cambodia, India, the Lao People's Democratic Republic, the Philippines, Thailand and Viet Nam. Thus, these tropical and subtropical countries exhibited earlier influenza activity peaks than temperate climate countries north of the equator. CONCLUSION: Most southern and south-eastern Asian countries lying north of the equator should consider vaccinating against influenza from April to June; countries near the equator without a distinct peak in influenza activity can base vaccination timing on local factors.
Authors: Julian W Tang; Florence Y L Lai; P Nymadawa; Yi-Mo Deng; Mala Ratnamohan; Martin Petric; Tze Ping Loh; Nancy W S Tee; Dominic E Dwyer; Ian G Barr; Felix Y W Wong Journal: J Med Virol Date: 2010-11 Impact factor: 2.327
Authors: Herman Kosasih; Alexander Klimov; Xu Xiyan; Stephen Lindstrom; Frank Mahoney; Charmagne Beckett; Timothy H Burgess; Patrick J Blair; Timothy M Uyeki; Endang R Sedyaningsih Journal: Influenza Other Respir Viruses Date: 2013-05 Impact factor: 4.380
Authors: Lin Yang; Stefan Ma; Ping Yan Chen; Jian Feng He; King Pan Chan; Angela Chow; Chun Quan Ou; Ai Ping Deng; Anthony J Hedley; Chit Ming Wong; J S Malik Peiris Journal: Vaccine Date: 2011-09-28 Impact factor: 3.641
Authors: Nancy J Cox; Julian Hickling; Rebecca Jones; Guus F Rimmelzwaan; Linda C Lambert; John Boslego; Larisa Rudenko; Leena Yeolekar; James S Robertson; Joachim Hombach; Justin R Ortiz Journal: Vaccine Date: 2015-10-23 Impact factor: 3.641
Authors: Thi Thanh Le; Thu Hang Pham; Thi Hien Pham; Le Khanh Hang Nguyen; Co Thach Nguyen; Vu Mai Phuong Hoang; Thu Huong Tran; Vu Son Nguyen; Huong Giang Ngo; Quynh Mai Le Journal: Western Pac Surveill Response J Date: 2015-11-11
Authors: David Shapiro; Champica K Bodinayake; Ajith Nagahawatte; Vasantha Devasiri; Ruvini Kurukulasooriya; Jeremy Hsiang; Bradley Nicholson; Aruna Dharshan De Silva; Truls Østbye; Megan E Reller; Christopher W Woods; L Gayani Tillekeratne Journal: Am J Trop Med Hyg Date: 2017-07 Impact factor: 2.345
Authors: Mary Dawn T Co; Masanori Terajima; Stephen J Thomas; Richard G Jarman; Kamonthip Rungrojcharoenkit; Stefan Fernandez; In-Kyu Yoon; Darunee Buddhari; John Cruz; Francis A Ennis Journal: Viral Immunol Date: 2014-08-20 Impact factor: 2.257
Authors: Mark C Steinhoff; Joanne Katz; Janet A Englund; Subarna K Khatry; Laxman Shrestha; Jane Kuypers; Laveta Stewart; Luke C Mullany; Helen Y Chu; Steven C LeClerq; Naoko Kozuki; Monica McNeal; Adriana M Reedy; James M Tielsch Journal: Lancet Infect Dis Date: 2017-05-15 Impact factor: 25.071
Authors: Edith Nkwembe; Roxana Cintron; Wendy Sessions; Hugo Kavunga; Pelagie Babakazo; Léonie Manya; Jean Jacques Muyembe Journal: J Harmon Res Med Health Sci Date: 2016-12